Trial Profile
CLOpidogrel versus TIcagreLor for antiplatelet maintenance in DIAbetic patients (CLOTILDIA) CLOpidogrel versus TIcagreLor per la terapia antiaggregante di mantenimento nei pazienti DIAbetici sottoposti ad angioplastica coronarica(CLOTILDIA)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Ticagrelor (Primary) ; Aspirin
- Indications Diabetic angiopathies
- Focus Therapeutic Use
- Acronyms CLOTILDIA
- 14 Apr 2016 Status changed from recruiting to completed.
- 09 Mar 2014 New trial record